NASDAQ Composite opens in less than twelve hours and Catalyst Pharmaceuticals’s premarket value is already 2.54% down.
The last session, NASDAQ Composite finished with Catalyst Pharmaceuticals jumping 2.01% to $3.55. NASDAQ Composite rose 2.56% to $13,067.48, following last session’s upward trend on what was an all-around positive trend trading session.
Catalyst Pharmaceuticals’s last close was $3.55, 48.73% below its 52-week high of $5.28.
Catalyst Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was 2.01%, 0.77%, and 0.17%, respectively.
Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.20%, 4.79%, and 5.04%, respectively.